论文部分内容阅读
目的 总结人精子蛋白17 (sperm protein 17,SP17)在乳腺癌中的研究现状.方法 在PubMed、Web of Science、CNKI、万方等数据库中检索SP17在乳腺癌中的表达情况及其功能的研究,并对其结果进行综述.结果 目前研究发现SP17只在乳腺癌组织中表达,而在正常乳腺组织中不表达.有研究检测到SP17只在转移阶段的肿瘤细胞中被检测到;同时体外研究发现,SP17阳性表达的乳腺癌细胞可以被特异性T淋巴细胞杀死.结论 SP17具有成为乳腺癌免疫治疗新靶点的潜能,可能具有促进癌细胞迁移的作用,未来仍需更多研究证实其在乳腺癌发生及发展过程中的作用,进而加速SP17疫苗的研制及其在乳腺癌临床治疗中的应用.“,”Objective To summarize current research status of sperm protein 17 (SP17) in breast cancer.Method By searching PubMed,Web of Science,CNKI,and Wanfang databases,the studies about expression and function of SP 17 in the breast cancer were summarized.Results SP17 only expressed in the breast cancer tissue but not in the normal breast tissue.The result of the study showed that SP17 was only detected in the metastatic stage of tumor cells.The preclinical trails found that the breast cancer cells with SP17 positive expression could be killed by the specific T lymphocyte.Conclusions SP17 might be a potential target of immunotherapy of breast cancer,it might promote metastasis of cancer.More studies are needed to further explore its function in tumor development,thus accelerate its application in clinical practice.